Kukje to develop a new oral Carbapenem antibiotic

Published: 2005-07-15 06:56:00

Updated: 2005-07-15 06:56:00

Kukje pharmaceutical company announced that they jointly discovered two carbapenem antibiotics, KR-34008 and KR-34020 with Korea Institute of Chemical Technology (KRICT) and put them into the preclinical studies, which showed an excellent sensitivity against the resistant PBP bacteria.

Kukje said that their new antibiotics exhibited equivalent efficacies and pharmacological profiles to the n...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.